CEP170L expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.003800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.717400E-01
Normal-vs-Stage2
4.047600E-01
Normal-vs-Stage3
3.695400E-01
Normal-vs-Stage4
4.910600E-01
Stage1-vs-Stage2
5.349600E-01
Stage1-vs-Stage3
9.492600E-01
Stage1-vs-Stage4
1.510420E-01
Stage2-vs-Stage3
5.731800E-01
Stage2-vs-Stage4
3.129400E-01
Stage3-vs-Stage4
2.087200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.987200E-01
Normal-vs-AfricanAmerican
4.710400E-01
Normal-vs-Asian
3.453000E-01
Caucasian-vs-AfricanAmerican
2.652600E-01
Caucasian-vs-Asian
1.648620E-01
AfricanAmerican-vs-Asian
3.884400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.835400E-01
Normal-vs-Female
4.242400E-01
Male-vs-Female
5.869500E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
3.788400E-01
Normal-vs-Age(41-60Yrs)
4.284000E-01
Normal-vs-Age(61-80Yrs)
3.946000E-01
Normal-vs-Age(81-100Yrs)
3.512000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
5.500600E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
8.309400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.252600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.761640E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
7.558100E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.897900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
3.662200E-01
Normal-vs-Daily Drinker
3.416600E-01
Normal-vs-Weekly Drinker
4.024600E-01
Normal-vs-Occasional Drinker
4.416600E-01
Normal-vs-Social Drinker
4.838200E-01
Non Drinker-vs-Daily Drinker
3.063000E-01
Non Drinker-vs-Weekly Drinker
2.590000E-01
Non Drinker-vs-Occasional Drinker
9.156000E-02
Non Drinker-vs-Social Drinker
9.060500E-02
Daily Drinker-vs-Weekly Drinker
9.478000E-02
Daily Drinker-vs-Occasional Drinker
2.255500E-02
Daily Drinker-vs-Social Drinker
4.076500E-02
Weekly Drinker-vs-Occasional Drinker
4.837600E-01
Weekly Drinker-vs-Social Drinker
2.921600E-01
Occasional Drinker-vs-Social Drinker
6.143000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
N/A
Normal-vs-Grade 2
N/A
Normal-vs-Grade 3
N/A
Normal-vs-Grade 4
N/A
Grade 1-vs-Grade 2
3.212800E-01
Grade 1-vs-Grade 3
3.260200E-01
Grade 1-vs-Grade 4
N/A
Grade 2-vs-Grade 3
8.333000E-01
Grade 2-vs-Grade 4
N/A
Grade 3-vs-Grade 4
N/A
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.907800E-01
Normal-vs-NonDiabetic
3.870000E-01
Diabetic-vs-NonDiabetic
8.906200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
3.833000E-01
Normal-vs-NoPancreatitis
3.916200E-01
Pancreatitis-vs-NoPancreatitis
7.301000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.991200E-01
Normal-vs-N1
4.044600E-01
N0-vs-N1
8.101000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that the TPM values for gene considered is extremely low (TPM < 1).
*
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
2.868000E-01
Normal-vs-TP53-NonMutant
2.790000E-01
TP53-Mutant-vs-TP53-NonMutant
7.539000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
